Career Enhancement Program

项目摘要/摘要--CEP MSK胰腺孢子职业提升计划(CEP)的目标是支持和指导 最有前途和最有动力的早期调查人员，为他们的独立职业生涯做准备 翻译研究的重点是发生在胰腺的恶性肿瘤。CEP领导班子拥有强大的 出版记录，成功指导的历史，以及对教育/培训的持续承诺。这个 CEP将：1)招募职业生涯早期的研究人员到胰腺癌的翻译研究领域，以增强 孢子的整体翻译研究能力，为我们的节目带来了新鲜的想法和新的人才， 2)为这些人提供有效的翻译研究所需的学术基础和指导 胰腺癌。CEP基金，加上机构基金，将使我们能够支持最多两个 每年都有杰出的候选人。早期职业研究人员(应用型和基础型科学家、临床医生和 2年内对胰腺癌表现出兴趣的内科医生-科学家 来自MSK的研究，来自三机构计划(威尔·康奈尔医学院或 洛克菲勒大学)，或纽约市内外的机构将有资格申请。 申请将由CEP/DRP遴选委员会进行同行评审，该委员会由孢子组成 PIS、DRP和CEP领导人，MSK部门和分区主席，以及来自 MSK平等、多样性和包容性理事会。最有前途的候选人，最有功绩的候选人 将根据已定义的评审标准选择有指导的研究项目。我们将特别强调 关于招聘合格妇女和任职人数偏低人口的成员，以及侧重于 与胰腺癌的医疗保健差距有关的问题。CEP获奖者将准备一份个性化的 与他们的临床和/或实验室导师(S)一起制定发展计划，并参加各种教育 MSK中支持其职业发展的计划、会议和课程。CEP获奖者将拥有 完全访问所有孢子核心设施和专业知识，并将成为每月孢子的组成部分 会议，他们将在那里展示他们的研究成果。CEP获奖者将每年接受正式评估，并 培训将在适当的时候进行修改。CEP获奖者的成功衡量标准包括演讲/ 发表原创研究，成功争取独立研究支持，建立 新的合作，以及通过学术提升获得的机构认可。

PROJECT SUMMARY/ABSTRACT – CEP The goal of the Career Enhancement Program (CEP) of the MSK Pancreas SPORE is to support and mentor the most promising and motivated early-career investigators to prepare them for independent careers in translational research focused on malignancies arising in the pancreas. The CEP leadership team has a strong publication record, a history of successful mentorship, and a sustained commitment to education/training. The CEP will: 1) recruit early-career investigators to the field of translational research in pancreatic cancer to enhance the overall translational research capability of the SPORE and bring fresh ideas and new talent to our program, and 2) provide these individuals the scholarly basis and mentorship needed for effective translational research in pancreatic cancer. CEP funds, supplemented by institutional funds, will allow us to support up to two exceptional candidates each year. Early-career investigators (applied and basic scientists, clinicians, and physician-scientists within 2 years of their faculty appointment) with a demonstrated interest in pancreatic cancer research from MSK, from institutions within the Tri-Institutional Program (Weill Cornell Medical College or Rockefeller University), or institutions within and outside of New York City will be eligible to apply. Applications will be peer-reviewed by the CEP/DRP Selection Committee, which is composed of the SPORE PIs, DRP and CEP Leaders, select MSK Departmental and Divisional Chairs, and representatives from the MSK Equality, Diversity & Inclusion Council. The most promising candidates, with the most meritorious mentored research projects based on defined review criteria, will be selected. Special emphasis will be placed on recruiting qualified women and members of underrepresented populations, and on projects focused on issues pertaining to health care disparities in pancreatic cancer. CEP awardees will prepare an individualized development plan with their clinical and/or laboratory mentor(s), and take part in various educational programs, conferences, and curricula at MSK that support their career development. CEP awardees will have full access to all SPORE Core facilities and expertise, and will be an integral part of monthly SPORE meetings, where they will present their research. CEP recipients will be formally evaluated annually, and training will be modified when appropriate. Metrics of success for CEP awardees include presentation/ publication of original research, successful competition for independent research support, establishment of new collaborations, and institutional recognition by academic promotion.